InvestorsHub Logo
Followers 7
Posts 754
Boards Moderated 0
Alias Born 03/11/2020

Re: dia76ca post# 10232

Friday, 06/04/2021 3:19:32 PM

Friday, June 04, 2021 3:19:32 PM

Post# of 14944
The beast has awoken ….
Sorrento Announces Positive Results From Its License Partner, Kelun, on a Phase I Study of Safety and Pharmacokinetics of A166, a Novel HER2 ADC for Advanced HER2 Positive Breast Cancers.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRNE News